Ultrasound focusing compensation method and system

By determining the acoustic attenuation coefficient and sound speed of biological tissues in high-intensity focusing ultrasound technology and adjusting the output of ultrasonic transducer, the problems of intensity and phase deviation at the focus point are solved, and the consistency of ultrasonic focusing at different depths and in biological tissues is achieved. and accuracy improve the control effect of HIFU technology.

WO2024227383A1PCT designated stage expired Publication Date: 2024-11-07XSONICO TECHNOLOGY LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/082844
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-10-14
Filing Date
2024-03-21
Publication Date
2024-11-07

AI Technical Summary

Technical Problem

In high-intensity focusing ultrasound technology, due to the different attenuation and sound speed of ultrasound in biological tissues, the ultrasound intensity and phase deviation at the focus point are caused. Especially in multi-focus focusing and HIFU technology based on cavitation effect, it is impossible to effectively ablate the lesions. , resulting in the failure of the operation.

Method used

By determining the acoustic attenuation coefficient, penetration distance and sound speed of biological tissue, adjusting the output of the ultrasonic transducer, compensating the initial intensity and emission time of the ultrasonic wave, ensuring the consistency of the ultrasonic intensity and phase at the focus, and using calculation models and measurement data for accurate use calculate.

Benefits of technology

The ultrasonic focusing effect is consistent at different depths and biological tissues, which improves the accuracy and control effect of HIFU technology, avoids the different range of influence caused by changes in the focus depth, and ensures the consistent phase of each ultrasonic element at the focus.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024082844_07112024_PF_FP_ABST
    Figure CN2024082844_07112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention provides an ultrasound focusing compensation method and system. Ultrasound waves are attenuated in biological tissues, and have different ultrasonic velocities in different biological tissues; therefore, different ultrasonic intensities and phases can be formed when the ultrasound waves are focused on different parts in the biological tissues, resulting in different areas of influence being formed at different positions of the biological tissues, thereby not being conducive to accurate control of HIFU technology. In the focusing compensation method provided in the present invention, the initial intensity, transmitting time or initial phase of each ultrasonic element is compensated for by means of adjusting the output of an ultrasonic transducer, so that the problems in the prior art are overcome, and the same ultrasonic intensity and phase can still be maintained when high-intensity ultrasound is focused on different parts, thereby effectively improving the accuracy of the HIFU technology.
Need to check novelty before this filing date? Find Prior Art

Description

A method and system for ultrasonic focusing compensation Technical Field

[0001] The present invention relates to high-intensity focused ultrasound technology, and in particular to a method and system for ultrasound focusing compensation. Background Art

[0002] High-intensity focused ultrasound (HIFU) provides a noninvasive treatment for precise tumor ablation. Its fundamental principle is to concentrate ultrasound energy at a focal point, generating transient hyperthermia and cavitation effects there, thereby destroying the target tissue and achieving the surgical goal of "ablating" the lesion. HIFU treatment does not cause external incisions or damage normal tissue along the ultrasound path. It has been used in the clinical treatment of benign and malignant tumors, including uterine fibroids, liver cancer, kidney cancer, and breast cancer.

[0003] During ultrasound focusing, ultrasound attenuates in biological tissue and has varying speeds of sound in different tissues. Consequently, different ultrasound intensities are generated at the focal point when focused on different parts of the tissue. Furthermore, as ultrasound waves (ultrasound elements) from different directions pass through different tissues, the phases of the individual ultrasound elements at the focal point may also differ. Current HIFU technology primarily utilizes the high-temperature effect of high-intensity focused ultrasound (HIFU), which inherently requires excessive ultrasound energy to be concentrated at the focal point. This requires less precise control, and even when delivering ultrasound waves using a monolithic transducer, intensity and phase deviations at the focal point do not materially affect the procedure. However, for modes with lower focal energy overload, such as multi-focal HIFU and cavitation-based HIFU, monolithic transducer driving cannot eliminate the intensity and phase deviations of individual ultrasound waves at the focal point, potentially preventing ablation and leading to surgical failure. Summary of the Invention

[0004] Based on the problems existing in the prior art, the present invention provides a method and system for ultrasonic focusing compensation, and the technical solution is as follows:

[0005] In its first aspect, the present invention provides a method for ultrasound focusing compensation. Generally speaking, this method is applied to the control process of a HIFU device to improve the focusing effect of ultrasound at the focal point. Specifically, the method comprises the following steps:

[0006] S1. Determine the acoustic attenuation coefficient and penetration distance of each biological tissue along the ultrasound focusing path;

[0007] S2. Determine the ultrasound intensity at the focus;

[0008] S3. Compensate for the initial intensity of the ultrasound wave by adjusting the output of the ultrasonic transducer so that the intensity of the ultrasound wave at the focus remains consistent with the desired intensity.

[0009] Specifically, step S1 establishes a computational model of the target biological tissue to calculate the acoustic attenuation coefficient and penetration distance of each biological tissue along the ultrasound focusing path. This computational model is based on a pre-established theoretical model and is adjusted based on physiological data such as the age, weight, and size of the target biological tissue. In a preferred embodiment, step S1 measures the acoustic attenuation coefficient and penetration distance of each biological tissue along the ultrasound focusing path by performing MRI measurements on the biological tissue.

[0010] Specifically, step S2 determines the ultrasonic intensity at a certain depth region by the following formula (1):

[0011] (1)

[0012] Where I0 represents the initial intensity of the ultrasonic wave, α represents the acoustic attenuation coefficient, z represents the depth reached by the sound wave, and I(z) represents the ultrasonic intensity at that depth.

[0013] Based on the ultrasonic intensity at a certain depth obtained by formula (1), the initial intensity of the ultrasonic wave is compensated by adjusting the output of the ultrasonic transducer in step S3 so that the compensated initial intensity meets the following formula (2): (2)

[0014] Among them, I target The expected intensity is the ultrasound intensity at the target depth. Through the above focus compensation process, the ultrasound intensity at the focus can be kept the same at different penetration distances, achieving a good focus control effect.

[0015] Preferably, considering that the ultrasonic wave may pass through a variety of biological tissues and the biological tissues passed by each ultrasonic wave may be different, step S2 determines the ultrasonic intensity of the jth ultrasonic element at the focus by formula (3):

[0016] (3)

[0017] Among them, I j (z) represents the ultrasonic intensity at depth z, α ij represents the acoustic attenuation coefficient of the i-th biological tissue through which the ultrasound passes, z ij Indicates the distance the sound wave travels in the biological tissue.

[0018] Based on the ultrasound intensity at the focus obtained by formula (3), the initial intensity of the ultrasound wave is compensated by adjusting the output of the ultrasonic transducer in step S3 so that the compensated initial intensity meets the following formula (4):

[0019] (4)

[0020] Among them, I 0j represents the actual initial intensity of the jth ultrasonic element after compensation. Because the biological tissues along each ultrasonic path may vary, the initial intensity of each ultrasonic element must be determined separately. This focus compensation process more accurately maintains the same ultrasonic intensity at the focal point at different penetration distances, achieving excellent focus control.

[0021] Further preferably, considering that the different biological tissues on each ultrasonic path may also cause the phase of each ultrasonic element at the focus to deviate, step S1 also determines the sound velocity of each biological tissue on the ultrasonic focusing path, step S2 also determines the time required for each ultrasonic wave to reach the focus, and step S3 also compensates for the emission time of each ultrasonic wave by adjusting the output of the ultrasonic transducer, so that the phase of each ultrasonic wave at the focus remains consistent.

[0022] Specifically, similar to the other parameters mentioned above, step S1 can obtain the sound velocity of each biological tissue on the ultrasonic focusing path by establishing a calculation model of the target biological tissue, or can obtain it by performing B-mode ultrasonic measurement on the biological tissue.

[0023] Specifically, step S2 determines the time required for each ultrasonic wave to reach the focus using the following formula (5):

[0024] (5)

[0025] Among them, T j represents the time required for the jth ultrasonic element to reach the focus, v ij It represents the speed of the ultrasonic wave in the i-th biological tissue through which the j-th ultrasonic element passes.

[0026] Based on the time required for each ultrasonic wave to reach the focus obtained by formula (5), the emission time of each ultrasonic wave is compensated by adjusting the output of the ultrasonic transducer in step S3 so that the emission time delay of each ultrasonic wave conforms to formula (6):

[0027] (6)

[0028] in, is the emission time delay of the jth ultrasonic element, T target It is the preset time that each ultrasonic element is expected to focus at the focal point. This time cannot be less than the maximum time required for each ultrasonic element to reach the focal point.

[0029] In addition to compensating for the emission time of each ultrasonic wave, in an alternative solution, step S3 may also compensate for the initial phase of each ultrasonic wave when it is emitted by adjusting the output of the ultrasonic transducer according to the following formula (7), which can also keep the phase of each ultrasonic wave at the focus consistent:

[0030] (7)

[0031] in, is the phase compensation amount when the jth ultrasonic element is emitted, is the preset initial phase when each ultrasonic element is expected to focus at the focal point, and ω is the sound wave frequency.

[0032] In a second aspect of the present invention, a system for ultrasonic focusing compensation is provided, comprising an ultrasonic transducer, a computer, and a controller, wherein the ultrasonic transducer is used to transmit sound waves, the computer is used to execute the aforementioned ultrasonic focusing compensation method to obtain a required ultrasonic focusing compensation amount, and the controller is used to control the output of the ultrasonic transducer according to the required ultrasonic focusing compensation amount.

[0033] According to the method and system for ultrasonic focusing compensation provided by the present invention, the present invention achieves the following technical effects:

[0034] This invention enables high-intensity focused ultrasound (HIFU) to maintain consistent intensity within biological tissues at varying depths, avoiding the uneven range of HIFU influence when the focal depth changes, effectively improving the ultrasound focusing effect. Furthermore, the invention overcomes the effects of varying biological tissue along the ultrasound path in complex focusing scenarios, maintaining the same phase of each ultrasound element at the focal point, achieving excellent focusing and making the HIFU control process more precise.

[0035] The above describes some of the technical effects achieved by the present invention. It should be understood that this Summary is provided to introduce a selection of concepts in a simplified form, which will be further described in the detailed description below. This Summary is not intended to identify key features or essential features of the present invention, nor is it intended to limit the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] The above and other objects, features and advantages of the present invention will become more apparent through a more detailed description of exemplary embodiments of the present invention with reference to the accompanying drawings, wherein like reference numerals generally represent like components throughout the exemplary embodiments of the present invention.

[0037] FIG1 shows a schematic diagram of HIFU focusing in the prior art;

[0038] FIG2 is a schematic diagram showing the focusing of HIFU according to an embodiment of the present invention;

[0039] Explanation of the accompanying figures: 1-ultrasound transducer; 2-influence range of focused ultrasound. DETAILED DESCRIPTION

[0040] Embodiments of the present invention will be described in more detail below with reference to the accompanying drawings. Although embodiments of the present invention are shown in the accompanying drawings, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments set forth herein. Rather, these embodiments are provided to make the present invention more thorough and complete and to fully convey the scope of the present invention to those skilled in the art.

[0041] As used herein, the term "including" and its variations represent open inclusion, i.e., "including but not limited to." Unless otherwise stated, the term "or" means "and / or." The term "based on" means "based at least in part on." The terms "an example embodiment" and "an embodiment" mean "at least one example embodiment." The term "another embodiment" means "at least one additional embodiment." The terms "first," "second," etc. may refer to different or the same objects. Other explicit and implicit definitions may also be included below.

[0042] Figure 1 shows a schematic diagram of HIFU focusing in the prior art. As shown in Figure 1, as the focus depth gradually becomes shallower, the intensity of the focused ultrasound at the focal point gradually increases, causing the HIFU effect to gradually increase. This phenomenon is not conducive to the precise control of HIFU technology.

[0043] According to the disclosure of the present invention, this embodiment provides a preferred method for ultrasonic focusing compensation, which mainly includes the following steps:

[0044] Step S1. Determine the acoustic attenuation coefficient, penetration distance, and sound velocity of each biological tissue along the ultrasound focusing path;

[0045] Step S2. Determine the ultrasound intensity at the focus and the time required for each ultrasound wave to reach the focus;

[0046] Step S3. By adjusting the output of the ultrasonic transducer, the initial intensity and emission time of the ultrasonic waves are compensated so that the ultrasonic intensity at the focus is consistent with the expected intensity and the phases of the ultrasonic waves at the focus are consistent.

[0047] Specifically, step S1 preferably uses B-mode ultrasound measurement to determine the acoustic attenuation coefficient, penetration distance, and speed of sound for each biological tissue along the ultrasound focal path. Alternatively, these parameters can be calculated using a computational model. However, this requires pre-establishing a theoretical model of the biological tissue through experimentation or by consulting literature. This theoretical model is then adjusted based on actual physiological data such as age, weight, and size. While parameters derived from computational models may exhibit some deviation compared to B-mode ultrasound measurement, they can maintain appropriate accuracy while controlling costs.

[0048] According to the acoustic attenuation coefficient, penetration distance, and sound velocity determined in step S1, step S2 of the method can determine the ultrasonic intensity I at the focus according to the following formula: j (z) and the time T required for each ultrasound wave to reach the focus j :

[0049] (3)

[0050] (5)

[0051] Among them, α ij represents the acoustic attenuation coefficient of the i-th biological tissue through which the j-th ultrasonic element passes, z ij represents the distance that the sound wave travels in the biological tissue, v ij It should be understood that if the various ultrasound paths focused to the focal point pass through exactly the same biological tissue, such as muscle, fat, or bone, then the I of each ultrasound wave is j (z) and T j are the same, but usually, the actual situation does not conform to this ideal assumption, so focus compensation needs to be performed in step S3.

[0052] Specifically, step S3 of the method calculates the initial intensity I of each ultrasonic wave by the following formula: 0j Perform intensity compensation to ensure that the ultrasonic intensity of each ultrasonic wave is consistent at the focus:

[0053] (4)

[0054] At the same time, step S3 compensates the emission time of each ultrasonic wave by the following formula to ensure that the phase of each ultrasonic wave at the focus is consistent:

[0055] (6)

[0056] Among them, this embodiment selects the maximum time T required for each ultrasonic element to reach the focus max As T target , by delaying other ultrasonic Emitted, each ultrasonic wave at T max At the same time, they reach focus.

[0057] In another specific embodiment, step S3 can also compensate the initial phase of each ultrasonic wave by the following formula, which can also ensure that the phase of each ultrasonic wave at the focus is consistent:

[0058] (7)

[0059] in, is the phase compensation amount when the jth ultrasonic element is emitted, is the preset initial phase when each ultrasonic element is expected to focus at the focal point, and ω is the sound wave frequency.

[0060] By using the ultrasound focusing compensation method provided in this embodiment, as shown in FIG2 , as the focus position of the ultrasound transducer 1 changes in depth, the ultrasound intensity at the focus remains constant, and the phases of the various ultrasound elements remain consistent, making the ultrasound focusing of HIFU more precise and facilitating refined control of the HIFU technology.

[0061] While various embodiments of the present invention have been described above, the above descriptions are intended to be illustrative, non-exhaustive, and not limited to the disclosed embodiments. Many modifications and variations will be apparent to those skilled in the art without departing from the scope and spirit of the described embodiments. The terminology used herein is selected to best explain the principles of the embodiments, their practical applications, or improvements over the prior art, or to enable others skilled in the art to understand the embodiments disclosed herein.

Claims

1. A method for ultrasonic focusing compensation, characterized in that: The following steps are involved: S1. Determine the acoustic attenuation coefficient and penetration distance of each biological tissue on the ultrasound focusing path; S2. Determine the ultrasound intensity at the focus; S3. By adjusting the output of the ultrasonic transducer, the initial intensity of the ultrasonic wave is compensated so that the ultrasonic intensity at the focus is consistent with the desired intensity; The step S2 determines the ultrasonic intensity of the jth ultrasonic element at the focus by the following formula: Among them, I j (z) represents the ultrasonic intensity of the ultrasonic wave at depth z, I0 represents the initial intensity of the ultrasonic wave, α ij represents the acoustic attenuation coefficient of the ith biological tissue through which the ultrasound passes, z ij It indicates the distance that the sound wave travels in the biological tissue; The step S3 compensates the initial intensity of the ultrasonic wave by adjusting the output of the ultrasonic transducer so that the compensated initial intensity meets the following formula: Among them, I 0j represents the actual initial intensity of the jth ultrasonic element after compensation, I target is the expected ultrasound intensity at the focus.

2. The method for ultrasonic focusing compensation according to claim 1, characterized in that: The step S1 calculates the acoustic attenuation coefficient and penetration distance of each biological tissue on the ultrasound focusing path by establishing a calculation model of the target biological tissue; The calculation model is obtained based on a pre-established theoretical model and adjusted according to the age, weight and size of the target biological tissue.

3. The method for ultrasonic focusing compensation according to claim 1, characterized in that: The step S1 performs MRI measurement on biological tissues and compares the measurement results with a database to obtain the acoustic attenuation coefficient and penetration distance of each biological tissue on the ultrasound focusing path.

4. The method for ultrasonic focusing compensation according to claim 1, characterized in that: The step S1 also determines the sound velocity of each biological tissue on the ultrasonic focusing path, the step S2 also determines the time required for each ultrasonic wave to reach the focus, and the step S3 also compensates for the emission time of each ultrasonic wave by adjusting the output of the ultrasonic transducer to keep the phase of each ultrasonic wave at the focus consistent.

5. The method for ultrasonic focusing compensation according to claim 4, characterized in that: The step S2 determines the time required for each ultrasonic wave to reach the focus by the following formula: Among them, T j represents the time required for the jth ultrasonic element to reach the focus, v ij represents the ultrasonic sound velocity in the i-th biological tissue through which the j-th ultrasonic element passes, z ij It indicates the distance that the sound wave travels in the biological tissue; The step S3 compensates the emission time of each ultrasonic wave by adjusting the output of the ultrasonic transducer so that the emission time delay of each ultrasonic wave conforms to the following formula: in, is the emission time delay of the jth ultrasonic element, T target It is the time that each ultrasonic element is expected to focus at the focal point, which is not less than the maximum time required for each ultrasonic element to reach the focal point.

6. The method for ultrasonic focusing compensation according to claim 1, characterized in that: The step S1 also determines the sound velocity of each biological tissue on the ultrasonic focusing path, the step S2 also determines the time required for each ultrasonic wave to reach the focus, and the step S3 also compensates for the initial phase of each ultrasonic wave when it is emitted by adjusting the output of the ultrasonic transducer, so that the phase of each ultrasonic wave at the focus remains consistent.

7. The method for ultrasonic focusing compensation according to claim 6, characterized in that: The step S2 determines the time required for each ultrasonic wave to reach the focus by the following formula: Among them, T j represents the time required for the jth ultrasonic element to reach the focus, v ij represents the ultrasonic sound velocity in the i-th biological tissue through which the j-th ultrasonic element passes, z ij It indicates the distance that the sound wave travels in the biological tissue; The step S3 compensates the initial phase of each ultrasonic wave emission by adjusting the output of the ultrasonic transducer according to the following formula: in, is the phase compensation amount when the jth ultrasonic element is emitted, is the initial phase when each ultrasonic element is expected to be focused at the focal point, and ω is the sound wave frequency.

8. A system for ultrasonic focusing compensation, characterized in that: including an ultrasonic transducer, a computer, and a controller; The ultrasonic transducer is used to emit sound waves; The computer is used to execute the method for ultrasonic focusing compensation according to any one of claims 1 to 7; The controller is used to control the output of the ultrasonic transducer.

Citation Information

Patent Citations

  • Method and apparatus for generating focused ultrasonic waves with surface modulation

    CN103650031A

  • Ultrasound attenuation coefficient compensating system and liver fat detecting system based on ultrasound

    CN103932735A

  • Method for real-time measurement of sound field in body through adoption of ultrasound reflection echo

    CN107261345A

  • Ultrasonic imaging system, method and device

    CN108652672A

  • Transdermal drug delivery device adopting ultrasonic multi-point focusing emission and control method

    CN112023244A